Appraising the holistic value of Lenvatinib for radio-iodine refractory differentiated thyroid cancer: A multi-country study applying pragmatic MCDA

BACKGROUND: The objective of the study was to reveal through pragmatic MCDA (EVIDEM) the contribution of a broad range of criteria to the value of the orphan drug lenvatinib for radioiodine refractory differentiated thyroid cancer (RR-DTC) in country-specific contexts. METHODS: The study was designe...

Descripción completa

Detalles Bibliográficos
Autores principales: Wagner, Monika, Khoury, Hanane, Bennetts, Liga, Berto, Patrizia, Ehreth, Jenifer, Badia, Xavier, Goetghebeur, Mireille
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5393009/
https://www.ncbi.nlm.nih.gov/pubmed/28412971
http://dx.doi.org/10.1186/s12885-017-3258-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5393009/
https://www.ncbi.nlm.nih.gov/pubmed/28412971
http://dx.doi.org/10.1186/s12885-017-3258-9

Ejemplares similares